
Vas Narasimhan, Novartis CEO (Simon Dawson/Bloomberg via Getty Images)
Novartis offloads five eye drugs in deal worth up to $175M
Eye care pharma company Harrow said this morning that it’s acquiring the US rights to five different drugs from the Swiss pharma Novartis for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.